Literature DB >> 28885920

Antibiotic Therapy for Acute Watery Diarrhea and Dysentery.

David R Tribble1.   

Abstract

Diarrheal disease affects a large proportion of military personnel deployed to developing countries, resulting in decreased job performance and operational readiness. Travelers' diarrhea is self-limiting and generally resolves within 5 days; however, antibiotic treatment significantly reduces symptom severity and duration of illness. Presently, azithromycin is the preferred first-line antibiotic for the treatment of acute watery diarrhea (single dose 500 mg), as well as for febrile diarrhea and dysentery (single dose 1,000 mg). Levofloxacin and ciprofloxacin are also options for acute watery diarrhea (single dose 500 mg and 750 mg, respectively) and febrile diarrhea/dysentery in areas with high rates of Shigella (500 mg once for 3 days [once daily with levofloxacin and twice daily with ciprofloxacin]), but are becoming less effective because of increasing fluoroquinolone resistance, particularly among Campylobacter spp. Another alternate for acute watery diarrhea is rifaximin (200 mg 3 times per day for 3 days); however, it should not be used with invasive illness. Use of loperamide in combination with antibiotic treatment is also beneficial as it has been shown to further reduce gastrointestinal symptoms and duration of illness. Because of regional differences in the predominance of pathogens and resistance levels, choice of antibiotic should take travel destination into consideration. Reprint &
Copyright © 2017 Association of Military Surgeons of the U.S.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28885920      PMCID: PMC5650106          DOI: 10.7205/MILMED-D-17-00068

Source DB:  PubMed          Journal:  Mil Med        ISSN: 0026-4075            Impact factor:   1.437


  58 in total

1.  Risk factors for the development of extended-spectrum beta-lactamase-producing bacteria in nonhospitalized patients.

Authors:  R Colodner; W Rock; B Chazan; N Keller; N Guy; W Sakran; R Raz
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2004-02-19       Impact factor: 3.267

2.  Epidemiology and outcome of Shigella, Salmonella and Campylobacter infections in travellers returning from the tropics with fever and diarrhoea.

Authors:  E Bottieau; J Clerinx; E Vlieghe; M Van Esbroeck; J Jacobs; A Van Gompel; J Van Den Ende
Journal:  Acta Clin Belg       Date:  2011 May-Jun       Impact factor: 1.264

Review 3.  Post-infectious sequelae of travelers' diarrhea.

Authors:  Bradley A Connor; Mark S Riddle
Journal:  J Travel Med       Date:  2013-07-09       Impact factor: 8.490

Review 4.  Military importance of diarrhea: lessons from the Middle East.

Authors:  John W Sanders; Shannon D Putnam; Mark S Riddle; David R Tribble
Journal:  Curr Opin Gastroenterol       Date:  2005-01       Impact factor: 3.287

5.  A randomized, double-blind, multicenter study of rifaximin compared with placebo and with ciprofloxacin in the treatment of travelers' diarrhea.

Authors:  David N Taylor; A Louis Bourgeois; Charles D Ericsson; Robert Steffen; Zhi-Dong Jiang; Jane Halpern; Robert Haake; Herbert L Dupont
Journal:  Am J Trop Med Hyg       Date:  2006-06       Impact factor: 2.345

6.  Trends in antibiotic resistance among diarrheal pathogens isolated in Thailand over 15 years.

Authors:  C W Hoge; J M Gambel; A Srijan; C Pitarangsi; P Echeverria
Journal:  Clin Infect Dis       Date:  1998-02       Impact factor: 9.079

Review 7.  Levofloxacin: a review of its use in the treatment of bacterial infections in the United States.

Authors:  Katherine F Croom; Karen L Goa
Journal:  Drugs       Date:  2003       Impact factor: 9.546

Review 8.  Effect of adjunctive loperamide in combination with antibiotics on treatment outcomes in traveler's diarrhea: a systematic review and meta-analysis.

Authors:  Mark S Riddle; Sarah Arnold; David R Tribble
Journal:  Clin Infect Dis       Date:  2008-10-15       Impact factor: 9.079

9.  Past trends and current status of self-reported incidence and impact of disease and nonbattle injury in military operations in Southwest Asia and the Middle East.

Authors:  Mark S Riddle; David R Tribble; Shannon D Putnam; Manal Mostafa; Theodore R Brown; Andrew Letizia; Adam W Armstrong; John W Sanders
Journal:  Am J Public Health       Date:  2008-10-15       Impact factor: 9.308

10.  Loperamide plus azithromycin more effectively treats travelers' diarrhea in Mexico than azithromycin alone.

Authors:  Charles D Ericsson; Herbert L DuPont; Pablo C Okhuysen; Zhi-Dong Jiang; Margaret W DuPont
Journal:  J Travel Med       Date:  2007 Sep-Oct       Impact factor: 8.490

View more
  11 in total

1.  A disease severity scale for the evaluation of vaccine and other preventive or therapeutic interventions for travellers' diarrhoea.

Authors:  Nicole Maier; Mark S Riddle; Ramiro Gutiérrez; Jamie A Fraser; Patrick Connor; David R Tribble; Chad K Porter
Journal:  J Travel Med       Date:  2022-01-17       Impact factor: 39.194

2.  Treatment of Enteropathogenic Escherichia coli Diarrhea in Cancer Patients: A Series of Three Cases.

Authors:  James D Denham; Sowmya Nanjappa; John N Greene
Journal:  Case Rep Infect Dis       Date:  2018-04-19

3.  Infectious diseases during the European Union training mission Mali (EUTM MLI) - a four-year experience.

Authors:  Hagen Frickmann; Ralf Matthias Hagen; Florian Geiselbrechtinger; Nagpal Hoysal
Journal:  Mil Med Res       Date:  2018-05-31

4.  Antibiotic Resistance of Campylobacter Species in a Pediatric Cohort Study.

Authors:  Francesca Schiaffino; Josh M Colston; Maribel Paredes-Olortegui; Ruthly François; Nora Pisanic; Rosa Burga; Pablo Peñataro-Yori; Margaret N Kosek
Journal:  Antimicrob Agents Chemother       Date:  2019-01-29       Impact factor: 5.191

5.  A glimpse of antimicrobial resistance gene diversity in kefir and yoghurt.

Authors:  Adrienn Gréta Tóth; István Csabai; Gergely Maróti; Ákos Jerzsele; Attila Dubecz; Árpád V Patai; Maura Fiona Judge; Sára Ágnes Nagy; László Makrai; Krisztián Bányai; Géza Szita; Norbert Solymosi
Journal:  Sci Rep       Date:  2020-12-31       Impact factor: 4.379

6.  Safety and immunogenicity of intramuscularly administered CS6 subunit vaccine with a modified heat-labile enterotoxin from enterotoxigenic Escherichia coli.

Authors:  Tida Lee; Ramiro L Gutiérrez; Milton Maciel; Steven Poole; Kayla J Testa; Stefanie Trop; Christopher Duplessis; Alison Lane; Mark S Riddle; Melinda Hamer; Ashley Alcala; Michael Prouty; Nicole Maier; Rahsan Erdem; A Louis Bourgeois; Chad K Porter
Journal:  Vaccine       Date:  2021-08-18       Impact factor: 3.641

7.  Effect of biannual azithromycin distribution on antibody responses to malaria, bacterial, and protozoan pathogens in Niger.

Authors:  Diana L Martin; Benjamin F Arnold; Ahmed M Arzika; Ramatou Maliki; E Brook Goodhew; Eric Rogier; Jeffrey W Priest; Elodie Lebas; Kieran S O'Brien; Victoria Le; Catherine E Oldenburg; Thuy Doan; Travis C Porco; Jeremy D Keenan; Thomas M Lietman
Journal:  Nat Commun       Date:  2022-02-21       Impact factor: 17.694

8.  Fecal Microbiota Functional Gene Effects Related to Single-Dose Antibiotic Treatment of Travelers' Diarrhea.

Authors:  Ryan C Johnson; Joy D Van Nostrand; Michele Tisdale; Brett Swierczewski; Mark P Simons; Patrick Connor; Jamie Fraser; Angela R Melton-Celsa; David R Tribble; Mark S Riddle
Journal:  Open Forum Infect Dis       Date:  2021-05-28       Impact factor: 3.835

Review 9.  Effects of Psychological, Environmental and Physical Stressors on the Gut Microbiota.

Authors:  J Philip Karl; Adrienne M Hatch; Steven M Arcidiacono; Sarah C Pearce; Ida G Pantoja-Feliciano; Laurel A Doherty; Jason W Soares
Journal:  Front Microbiol       Date:  2018-09-11       Impact factor: 5.640

Review 10.  Shigella sonnei: virulence and antibiotic resistance.

Authors:  Ahtesham Ahmad Shad; Wajahat Ahmed Shad
Journal:  Arch Microbiol       Date:  2020-09-14       Impact factor: 2.552

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.